Search Results 511-520 of 19202 for Hemoglobin

  1. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

    Hemoglobin ≤ 11 g/dL; Hyperviscosity syndrome or measured viscosity level of ≥ 4 centipoise. NOTE: for these patients it is strongly recommended that they ...

  2. Thalassemia - Doctors and departments - Mayo Clinic

    Related. Associated Procedures. Amniocentesis · Blood transfusion · Bone marrow transplant · Complete blood count (CBC) · Genetic testing · Hemoglobin test.

  3. A Study Assessing HMB-002 In Participants With Von Willebrand Disease - Mayo Clinic

    Hematology (Hgb): Hemoglobin >85 g/L and platelet count >120 x 10^9/L. PART B ONLY- Participants must be symptomatic (typically reporting bleeding events ...

  4. A Study to Evaluate Infigratinib to Treat Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302) - Mayo Clinic

    Hemoglobin 1 week before randomization and hemoglobin remains stable. Have insufficient hepatic and renal function: Total bilirubin > 1.5 × upper limit of ...

  5. A Study to Evaluate AntiThrombotic Therapy to Lessen Complications of COVID-19 (Enrolling by Invitation Only) - Mayo Clinic

    Hemoglobin < 80 g/L (to minimize the likelihood of requiring red blood cell transfusion if potential bleeding were to occur). Acute or subacute bacterial ...

  6. Clinical Trials - Tesevatinib in Subjects With ADPKD

    Hemoglobin > 9 g/dL;; Total bilirubin ≤ 1.5 mg/dL;; Aspartate aminotransferase < 2.5 × ULN;; Alanine aminotransferase < 2.5 × ULN;; Prothrombin time/partial ...

  7. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Hemoglobin >= 9.0 g/dL (hemoglobin may be supported by transfusion); Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 2.5 x ULN (=< 5 x ...

  8. Melatonin Effects On Cardiovascular Disease Mechanisms In The Menopause Transition: A Randomized Clinical Trial

    * History of clinically diagnosed anemia or low hemoglobin levels (\<11.6 g/dL) within the past 12 months * Active cancer * Severe daytime sleepiness (score ...

  9. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL. Platelet count ≥ 75,000/mm^3. Absolute neutrophil count (ANC) ≥ 1,500/mm^3. Creatinine ≤ 1.5 x upper limit of normal (ULN) OR ...

  10. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...